Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis

Andrea Granados, Christine L. Chan, Katie Larson Ode, Amir Moheet, Antoinette Moran, Reinhard Holl

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Cystic fibrosis related diabetes (CFRD) is a distinct form of diabetes that is associated with significantly increased morbidity and mortality in the CF population. The primary etiology is relative insulin insufficiency secondary to destruction of pancreatic islets, and to other factors that affect the function of the remaining beta cells. The prevalence of CFRD increases markedly with age and more than half of CF adults develop the disease. As the initial presentation of CFRD may be clinically silent, annual screening is recommended starting at least by the age of 10 with an oral glucose tolerance test (OGTT). The importance of an early diagnosis is based on the association of diabetes and abnormal glucose tolerance with worse health outcomes in patients with CF, and evidence that early treatment of diabetes improves prognosis. This review presents a concise overview of the current understanding of CFRD pathogenesis, natural history, screening and diagnosis.

Original languageEnglish (US)
Pages (from-to)S3-S9
JournalJournal of Cystic Fibrosis
Volume18
DOIs
StatePublished - Oct 2019

Fingerprint

Cystic Fibrosis
Glucose Tolerance Test
Natural History
Islets of Langerhans
Early Diagnosis
Insulin
Morbidity
Glucose
Mortality
Health
Population
Therapeutics

Keywords

  • Cystic fibrosis
  • Cystic fibrosis related diabetes
  • Diagnosis
  • Pathophysiology
  • Screening

PubMed: MeSH publication types

  • Journal Article

Cite this

Cystic fibrosis related diabetes : Pathophysiology, screening and diagnosis. / Granados, Andrea; Chan, Christine L.; Ode, Katie Larson; Moheet, Amir; Moran, Antoinette; Holl, Reinhard.

In: Journal of Cystic Fibrosis, Vol. 18, 10.2019, p. S3-S9.

Research output: Contribution to journalArticle

Granados, Andrea ; Chan, Christine L. ; Ode, Katie Larson ; Moheet, Amir ; Moran, Antoinette ; Holl, Reinhard. / Cystic fibrosis related diabetes : Pathophysiology, screening and diagnosis. In: Journal of Cystic Fibrosis. 2019 ; Vol. 18. pp. S3-S9.
@article{b6137935b8804034934239d898aeb4bd,
title = "Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis",
abstract = "Cystic fibrosis related diabetes (CFRD) is a distinct form of diabetes that is associated with significantly increased morbidity and mortality in the CF population. The primary etiology is relative insulin insufficiency secondary to destruction of pancreatic islets, and to other factors that affect the function of the remaining beta cells. The prevalence of CFRD increases markedly with age and more than half of CF adults develop the disease. As the initial presentation of CFRD may be clinically silent, annual screening is recommended starting at least by the age of 10 with an oral glucose tolerance test (OGTT). The importance of an early diagnosis is based on the association of diabetes and abnormal glucose tolerance with worse health outcomes in patients with CF, and evidence that early treatment of diabetes improves prognosis. This review presents a concise overview of the current understanding of CFRD pathogenesis, natural history, screening and diagnosis.",
keywords = "Cystic fibrosis, Cystic fibrosis related diabetes, Diagnosis, Pathophysiology, Screening",
author = "Andrea Granados and Chan, {Christine L.} and Ode, {Katie Larson} and Amir Moheet and Antoinette Moran and Reinhard Holl",
year = "2019",
month = "10",
doi = "10.1016/j.jcf.2019.08.016",
language = "English (US)",
volume = "18",
pages = "S3--S9",
journal = "Journal of Cystic Fibrosis",
issn = "1569-1993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Cystic fibrosis related diabetes

T2 - Pathophysiology, screening and diagnosis

AU - Granados, Andrea

AU - Chan, Christine L.

AU - Ode, Katie Larson

AU - Moheet, Amir

AU - Moran, Antoinette

AU - Holl, Reinhard

PY - 2019/10

Y1 - 2019/10

N2 - Cystic fibrosis related diabetes (CFRD) is a distinct form of diabetes that is associated with significantly increased morbidity and mortality in the CF population. The primary etiology is relative insulin insufficiency secondary to destruction of pancreatic islets, and to other factors that affect the function of the remaining beta cells. The prevalence of CFRD increases markedly with age and more than half of CF adults develop the disease. As the initial presentation of CFRD may be clinically silent, annual screening is recommended starting at least by the age of 10 with an oral glucose tolerance test (OGTT). The importance of an early diagnosis is based on the association of diabetes and abnormal glucose tolerance with worse health outcomes in patients with CF, and evidence that early treatment of diabetes improves prognosis. This review presents a concise overview of the current understanding of CFRD pathogenesis, natural history, screening and diagnosis.

AB - Cystic fibrosis related diabetes (CFRD) is a distinct form of diabetes that is associated with significantly increased morbidity and mortality in the CF population. The primary etiology is relative insulin insufficiency secondary to destruction of pancreatic islets, and to other factors that affect the function of the remaining beta cells. The prevalence of CFRD increases markedly with age and more than half of CF adults develop the disease. As the initial presentation of CFRD may be clinically silent, annual screening is recommended starting at least by the age of 10 with an oral glucose tolerance test (OGTT). The importance of an early diagnosis is based on the association of diabetes and abnormal glucose tolerance with worse health outcomes in patients with CF, and evidence that early treatment of diabetes improves prognosis. This review presents a concise overview of the current understanding of CFRD pathogenesis, natural history, screening and diagnosis.

KW - Cystic fibrosis

KW - Cystic fibrosis related diabetes

KW - Diagnosis

KW - Pathophysiology

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=85073665691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073665691&partnerID=8YFLogxK

U2 - 10.1016/j.jcf.2019.08.016

DO - 10.1016/j.jcf.2019.08.016

M3 - Article

C2 - 31679726

AN - SCOPUS:85073665691

VL - 18

SP - S3-S9

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

SN - 1569-1993

ER -